Michael Ackerman

From Rutgers Medical Informatics History Project

Revision as of 18:19, 26 January 2012 by Mcgrew (Talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search

Michaelackerman.gif

Name: Michael J. Ackerman, Ph.D

Elected ACMI Fellow: 1985

Birthdate:

Degrees: Biomedical Engineering, UNC Chapel Hill

Current Position: NLM's Assistant Director for High Performance Computing and Communications

Current email:

Professional Affiliations:

Professional Activities: Board of Directors of the Symposium for Computer Applications in Medical Care (SCAMC) from 1976 to 1988; program chair for the 9th SCAMC and Finance Chair for Medinfo'86; founding member of the American Medical Informatics Association (AMIA); Editorial Boards of Telemedicine & e-Health, and the Journal of the American Medical Informatics Association

Honors and Awards: Founding Fellow of the American Institute of Medical and Biological Engineering (AIMBE) in 1992; 2008 National Library of Medicine Board of Regents Award, 2006 American Telemedical Association Decicated Service Award, 1998 Johns Hopkins University Ranice W. Crosby Distinguished Achievement Award, 1997 Government Technology Leadership Award, 1996 National Institutes of Health Director's Award, the 1996 Friends of the National Library of Medicine Public Service Award, the 1996 Satava Award for Medical Applications of Virtual Reality, the 1995 Public Health Service Special Recognition Award, the 1994 American Institute for Medical and Biological Engineering Dedicated Service Award, the 1993 and 2003 American Medical Informatics Association President's Awards, the 1993 Health Sciences Communications Association Special Achievement Award, and the 1992 National Institutes of Health Award of Merit. His work on the Visible Human Project was nominated as a finalist for a 1995 Discover Magazine Award for Technological Innovation in Software and a 1996 Smithsonian Award for Information Technology.

Other Works:

Other Information:

Curriculum Vitae:


Selected Publications:

TGFβ-inducible early gene-1 (TIEG1) mutations in hypertrophic cardiomyopathy.
Bos JM, Subramaniam M, Hawse JR, Christiaans I, Rajamannan NM, Maleszewski JJ, Edwards WD, Wilde AA, Spelsberg TC, Ackerman MJ. 2012

Variants in the 3' untranslated region of the KCNQ1-encoded Kv7.1 potassium channel modify disease severity in patients with type 1 long QT syndrome in an allele-specific manner.
Amin AS, Giudicessi JR, Tijsen AJ, Spanjaart AM, Reckman YJ, Klemens CA, Tanck MW, Kapplinger JD, Hofman N, Sinner MF, Müller M, Wijnen WJ, Tan HL, Bezzina CR, Creemers EE, Wilde AA, Ackerman MJ, Pinto YM. 2011

Connexin43 mutation causes heterogeneous gap junction loss and sudden infant death.
Van Norstrand DW, Asimaki A, Rubinos C, Dolmatova E, Srinivas M, Tester DJ, Saffitz JE, Duffy HS, Ackerman MJ. 2012

A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents.
Hu D, Barajas-Martínez H, Medeiros-Domingo A, Crotti L, Veltmann C, Schimpf R, Urrutia J, Alday A, Casis O, Pfeiffer R, Burashnikov E, Caceres G, Tester DJ, Wolpert C, Borggrefe M, Schwartz P, Ackerman MJ, Antzelevitch C. 2011

QTc values among children and adolescents presenting to the emergency department.
Van Dorn CS, Johnson JN, Taggart NW, Thorkelson L, Ackerman MJ.	2011

Congenital type 1 long QT syndrome unmasked by a highly caffeinated energy drink.
Dufendach KA, Horner JM, Cannon BC, Ackerman MJ. 2011

Unexplained drownings and the cardiac channelopathies: a molecular autopsy series.
Tester DJ, Medeiros-Domingo A, Will ML, Ackerman MJ. 2011

Meaningful images., Ackerman MJ. 2011

Trigger-specific ion-channel mechanisms, risk factors, and response to therapy in type 1 long QT syndrome.
Goldenberg I, Thottathil P, Lopes CM, Moss AJ, McNitt S, O-Uchi J, Robinson JL, Zareba W, Ackerman MJ, Kaufman ES, Towbin JA, Vincent M, Barsheshet A.,	2012

Call for a Sudden Cardiac Death Registry: Should Reporting of Sudden Cardiac Death be Mandatory?
Campbell RM, Berger S, Ackerman MJ, Batra AS., 2011

Loss-of-function mutations in the KCNJ8-encoded Kir6.1 K(ATP) channel and sudden infant death syndrome.
Tester DJ, Tan BH, Medeiros-Domingo A, Song C, Makielski JC, Ackerman MJ., 2011

Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations.
Olivotto I, Girolami F, Sciagrà R, Ackerman MJ, Sotgia B, Bos JM, Nistri S, Sgalambro A, Grifoni C, Torricelli F, Camici PG, Cecchi F.,	2011

Risk of syncope in family members who are genotype-negative for a family-associated long-QT syndrome mutation.
Barsheshet A, Moss AJ, McNitt S, Polonsky S, Lopes CM, Zareba W, Robinson JL, Ackerman MJ, Benhorin J, Kaufman ES, Towbin JA, Vincent GM, Qi M, Goldenberg I., 2011

HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership
between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).
Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, Camm AJ, Ellinor PT, Gollob M, Hamilton R, Hershberger RE, Judge DP, Le Marec H,
McKenna WJ, Schulze-Bahr E, Semsarian C, Towbin JA, Watkins H, Wilde A, Wolpert C, Zipes DP; Heart Rhythm Society (HRS); European Heart                                                                                                                                 
Rhythm Association (EHRA). 2011

HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed
as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).
Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, Camm AJ, Ellinor PT, Gollob M, Hamilton R, Hershberger RE, Judge DP, Le Marec H,
McKenna WJ, Schulze-Bahr E, Semsarian C, Towbin JA, Watkins H, Wilde A, Wolpert C, Zipes DP., 2011

The diagnostic utility of recovery phase QTc during treadmill exercise stress testing in the evaluation of long QT syndrome.
Horner JM, Horner MM, Ackerman MJ. 2011

Anesthetic management of patients with Brugada syndrome: a case series and literature review.
Kloesel B, Ackerman MJ, Sprung J, Narr BJ, Weingarten TN., 2011

Left ventricular noncompaction syndrome masquerading or misdiagnosed as congenital long QT syndrome: remember QT prolongation does not equal long QT syndrome.
Coleman MA, Bos JM, Phillips SD, Souza JJ, Ackerman MJ., 2011

Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise.
Kapplinger JD, Landstrom AP, Salisbury BA, Callis TE, Pollevick GD, Tester DJ, Cox MG, Bhuiyan Z, Bikker H, Wiesfeld AC, Hauer RN, van Tintelen JP, Jongbloed JD, Calkins H, Judge DP, Wilde AA, Ackerman MJ., 2011

Risk of recurrent cardiac events after onset of menopause in women with congenital long-QT syndrome types 1 and 2.
Buber J, Mathew J, Moss AJ, Hall WJ, Barsheshet A, McNitt S, Robinson JL, Zareba W, Ackerman MJ, Kaufman ES, Luria D, Eldar M, Towbin JA, Vincent M, Goldenberg I., 2011

Books

Human anatomy : from the Renaissance to the digital age / Benjamin A. Rifkin ; Michael J. Ackerman ; biographies by Judith Folkenberg, 2006

Human Anatomy: Depicting the Body from the Renaissance to Today. Benjamin A. Rifkin, Michael J. Ackerman,
Judith Folkenberg 2011

Additional Media:


Sources:
NIH NLM

Personal tools